|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/02 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2992016 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14724662.3 |
| Date of filing the European patent application | 2014-04-30 | |
| (97) | Date of publication of the European application | 2016-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
| (46) | Date of publication of the claims translation | 2018-01-10 |
| (86) | Number | PCT/EP2014/058827 |
| Date | 2014-04-30 |
| (87) | Number | WO 2014/177615 |
| Date | 2014-11-06 |
| (30) | Number | Date | Country code |
| 201361818821 P | 2013-05-02 | US |
| (72) |
KLEIN, Christian, CH
LANG, Sabine, CH
POLSON, Andrew G., US
UMANA, Pablo, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kombinuotas gydymas afukosilatu paveiktu CD20 antikūnu su CD79B antikūno ir vaisto konjugatu |
| COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79B ANTIBODY-DRUG CONJUGATE |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 13 | 289.00 EUR |
| 2027-04-30 |